Cargando…
Suppression of the photoparoxysmal response in photosensitive epilepsy with cenobamate (YKP3089)
OBJECTIVE: To evaluate the effect of cenobamate in patients with photoparoxysmal-EEG response (PPR) to intermittent photic stimulation (IPS) as proof of principle of efficacy in patients with epilepsy. METHODS: In this multicenter, single-blind study, adults with photosensitive epilepsy, with/withou...
Autores principales: | Kasteleijn- Nolst Trenite, Dorothee G.A., DiVentura, Bree D., Pollard, John R., Krauss, Gregory L., Mizne, Sarah, French, Jacqueline A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6709996/ https://www.ncbi.nlm.nih.gov/pubmed/31292226 http://dx.doi.org/10.1212/WNL.0000000000007894 |
Ejemplares similares
-
Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature
por: Rissardo, Jamir Pitton, et al.
Publicado: (2023) -
Kv7 potassium channel activation with ICA-105665 reduces photoparoxysmal EEG responses in patients with epilepsy
por: Kasteleijn-Nolst Trenité, Dorotheé G A, et al.
Publicado: (2013) -
Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients
por: Reed, Ronald C., et al.
Publicado: (2020) -
Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open‐label safety study
por: Sperling, Michael R., et al.
Publicado: (2020) -
Headache, epilepsy and photosensitivity: how are they connected?
por: Kasteleijn-Nolst Trenité, Dorothée G. A., et al.
Publicado: (2010)